anmelden
Candriam Equities L Biotechnology Class I Fonds
2.952,70
EUR
+53,50
EUR
+1,85
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,88% |
| Insmed Inc | US4576693075 | 4,35% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,15% |
| Amgen Inc | US0311621009 | 3,99% |
| Gilead Sciences Inc | US3755581036 | 3,96% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,96% |
| United Therapeutics Corp | US91307C1027 | 2,79% |
| Ionis Pharmaceuticals Inc | US4622221004 | 2,54% |
| Biogen Inc | US09062X1037 | 2,49% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 2,30% |
| Sonstige | 64,58% |